Skip to content

Acceptance and Commitment Therapy for patients with primary insomnia - a pilot study

Acceptance and Commitment Therapy for patients with primary insomnia - a pilot study - ACTIVE - Acceptance and Commitment Therapy for Insomnia - viability and efficacy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00004443
Enrollment
12
Registered
2012-12-03
Start date
2013-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F51.0

Interventions

Group 1: 6 weekly sessions of Acceptance and Commitment Therapy, length of sessions 120 minutes, outpatient setting

Sponsors

Universitätsklinikum Freiburg Universitätsklinik für Psychiatrie und Psychsomatik Abteilung für Psychiatrie und Psychotherapie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.meet diagnostic criteria for primary insomnia according to DSM-IV (American Psychiatric Association (APA), 1994) as assessed by experienced sleep clinicians based on a clinical interview including clinical sleep history and standard physical examinations 2.duration of insomnia for at least 6 months 3.insomnia at a clinical level, defined as a sleep onset latency or wakefulness after sleep onset of more than 30 minutes at least 3 times a week (Buysse et al., 2006) 4.previous unsuccessful treatment attempts: Patients who previously underwent CBT, including relaxation, sleep restriction, stimulus control, sleep hygiene and still fulfill criteria 1 to 3 at baseline will be included. 5.written informed consent after a detailed description of the study 6.age between 18 and 65 years

Exclusion criteria

Exclusion criteria: 1. other sleep disorders requiring other treatment, e.g. sleep apnea (AHI>10/h), restless legs syndrome, periodic limb movement disorder (PLMS index with arousal >5/h), narcolepsia or circadian rhythm disorders 2. relevant medical or psychiatric comorbidity, i.e. only patients who do not currently fulfill the diagnostic criteria for another disorder are eligible. Patients with a history of psychosis, affective disorder, substance abuse or dependency, borderline personality disorder or other relevant mental disorder will be excluded. 3. evidence of mental retardation, severe cognitive deficits and neurological disorders 4. concomitant other psychotherapy 5. any psychoactive medication, including benzodiazepines, benzodiazepine-receptor agonists, antidepressants, antipsychotics etc.

Design outcomes

Primary

MeasureTime frame
participants' subjective satisfaction with the intervention, measured by a) the Insomnia Treatment Satisfaction Survey and an ACT-specific treatment satisfaction scale, administered after the intervention and b) a measure of process quality ("Berner Stundenbogen") administered after every therapy session

Secondary

MeasureTime frame
subjective sleep quality as measured by the "Pittsburgh Sleep Quality Index" (PSQI) administered at pre, post and 3-months-follow-up

Countries

Germany

Contacts

Public ContactElisabeth Hertenstein

Universitätsklinik für Psychiatrie und Psychosomatik Abteilung für Psychiatrie und Psychotherapie

elisabeth.hertenstein@uniklinik-freiburg.de0761 270 69750

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026